speb/financial-data huggingface dataset:
PHR.LS balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 71573.00
PHR.LS income_statement (annual, 2022-12-31) — Total Other Finance Cost: 34407.00
PHR.LS balance_sheet (annual, 2022-12-31) — Total Tax Payable: 127420.00
PHR.LS income_statement (annual, 2022-12-31) — Total Unusual Items: -310426.00
PHR.LS income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -310426.00
PHR.LS balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 74689552.00
PHR.LS balance_sheet (annual, 2022-12-31) — Treasury Stock: 164809193.00
PHR.LS balance_sheet (annual, 2022-12-31) — Working Capital: 4177253.00
PHR.LS income_statement (annual, 2023-12-31) — +Operating Expense: 2261595.00
PHR.LS income_statement (annual, 2023-12-31) — +Total Revenue: 0.00
PHR.LS balance_sheet (annual, 2023-12-31) — Accounts Payable: 110141.00
PHR.LS balance_sheet (annual, 2023-12-31) — Accounts Receivable: 261895.00
PHR.LS balance_sheet (annual, 2023-12-31) — Available For Sale Securities: 130827.00
PHR.LS income_statement (annual, 2023-12-31) — Basic Average Shares: 821756654.00
PHR.LS income_statement (annual, 2023-12-31) — Basic EPS: 0.00
PHR.LS cash_flow (annual, 2023-12-31) — Beginning Cash Position: 20955489.00
PHR.LS cash_flow (annual, 2023-12-31) — Capital Expenditure: -7414.00
PHR.LS balance_sheet (annual, 2023-12-31) — Capital Stock: 26895375.00
PHR.LS balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 17196818.00
PHR.LS balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 17196818.00
PHR.LS balance_sheet (annual, 2023-12-31) — Cash Equivalents: 11600000.00
PHR.LS balance_sheet (annual, 2023-12-31) — Cash Financial: 5596818.00
PHR.LS cash_flow (annual, 2023-12-31) — Cash Flowsfromusedin Operating Activities Direct: 9334933.00
PHR.LS cash_flow (annual, 2023-12-31) — Changes In Cash: -3806649.00
PHR.LS cash_flow (annual, 2023-12-31) — Classesof Cash Payments: -2376711.00
PHR.LS cash_flow (annual, 2023-12-31) — Classesof Cash Receiptsfrom Operating Activities: 11755753.00
PHR.LS balance_sheet (annual, 2023-12-31) — Common Stock: 26895375.00
PHR.LS balance_sheet (annual, 2023-12-31) — Common Stock Equity: 68136817.00
PHR.LS income_statement (annual, 2023-12-31) — Cost Of Revenue: 310152.00
PHR.LS balance_sheet (annual, 2023-12-31) — Current Assets: 17528731.00
PHR.LS balance_sheet (annual, 2023-12-31) — Current Deferred Assets: 8533.00
PHR.LS balance_sheet (annual, 2023-12-31) — Current Liabilities: 27161495.00
PHR.LS income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 40338.00
PHR.LS income_statement (annual, 2023-12-31) — Depreciation Income Statement: 40338.00
PHR.LS income_statement (annual, 2023-12-31) — Diluted Average Shares: 821756654.00
PHR.LS income_statement (annual, 2023-12-31) — Diluted EPS: 0.00
PHR.LS income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -967192.00
PHR.LS income_statement (annual, 2023-12-31) — EBIT: -2261595.00
PHR.LS income_statement (annual, 2023-12-31) — EBITDA: -2221257.00
PHR.LS cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 48012.00
PHR.LS cash_flow (annual, 2023-12-31) — End Cash Position: 17196818.00
PHR.LS balance_sheet (annual, 2023-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 25822428.00
PHR.LS cash_flow (annual, 2023-12-31) — Financing Cash Flow: -2088.00
PHR.LS cash_flow (annual, 2023-12-31) — Free Cash Flow: 9327519.00
PHR.LS income_statement (annual, 2023-12-31) — General And Administrative Expense: 274495.00
PHR.LS income_statement (annual, 2023-12-31) — Gross Profit: -310152.00
PHR.LS income_statement (annual, 2023-12-31) — Interest Income: 178933.00
PHR.LS income_statement (annual, 2023-12-31) — Interest Income Non Operating: 178933.00
PHR.LS cash_flow (annual, 2023-12-31) — Interest Paid Cff: -2088.00
PHR.LS cash_flow (annual, 2023-12-31) — Interest Received Cfi: 60802.00
PHR.LS balance_sheet (annual, 2023-12-31) — Invested Capital: 68186688.00
PHR.LS cash_flow (annual, 2023-12-31) — Investing Cash Flow: -13139494.00
PHR.LS balance_sheet (annual, 2023-12-31) — Investmentin Financial Assets: 25953255.00
PHR.LS balance_sheet (annual, 2023-12-31) — Long Term Debt: 49871.00
PHR.LS balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 49871.00
PHR.LS cash_flow (annual, 2023-12-31) — Long Term Debt Payments: 0.00
PHR.LS balance_sheet (annual, 2023-12-31) — Long Term Provisions: 75775.00
PHR.LS income_statement (annual, 2023-12-31) — Net Income: -967192.00
PHR.LS income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -967192.00
PHR.LS income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -967192.00
PHR.LS income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -967192.00
PHR.LS income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -967192.00
PHR.LS income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -967192.00
PHR.LS income_statement (annual, 2023-12-31) — Net Interest Income: 162563.00
PHR.LS cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -13192883.00
PHR.LS cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 0.00
PHR.LS cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 0.00
PHR.LS income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 162563.00
PHR.LS cash_flow (annual, 2023-12-31) — Net Other Investing Changes: 1.00
PHR.LS balance_sheet (annual, 2023-12-31) — Net PPE: 35502.00
PHR.LS cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -7414.00
PHR.LS balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 68136817.00
PHR.LS income_statement (annual, 2023-12-31) — Normalized EBITDA: -3354111.00
PHR.LS income_statement (annual, 2023-12-31) — Normalized Income: -1862146.66
PHR.LS income_statement (annual, 2023-12-31) — Operating Income: -2261595.00
PHR.LS income_statement (annual, 2023-12-31) — Operating Revenue: 0.00
PHR.LS balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 821822948.00
PHR.LS cash_flow (annual, 2023-12-31) — Other Cash Adjustment Outside Changein Cash: -34.00
PHR.LS cash_flow (annual, 2023-12-31) — Other Cash Receiptsfrom Operating Activities: 11755753.00
PHR.LS balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 26644990.00
PHR.LS balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 51906470.00
PHR.LS balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 1.00
PHR.LS income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: -85758.00
PHR.LS income_statement (annual, 2023-12-31) — Other Operating Expenses: 1097653.00
PHR.LS balance_sheet (annual, 2023-12-31) — Other Payable: 6162.00
PHR.LS income_statement (annual, 2023-12-31) — Other Special Charges: -1132854.00
PHR.LS income_statement (annual, 2023-12-31) — Otherunder Preferred Stock Dividend: 0.00
PHR.LS balance_sheet (annual, 2023-12-31) — Payables: 247338.00
PHR.LS cash_flow (annual, 2023-12-31) — Paymentson Behalfof Employees: -858184.00
PHR.LS cash_flow (annual, 2023-12-31) — Paymentsto Suppliersfor Goodsand Services: -1518527.00
PHR.LS balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 154494.00
PHR.LS income_statement (annual, 2023-12-31) — Pretax Income: -942568.00
PHR.LS cash_flow (annual, 2023-12-31) — Purchase Of Investment: -16388217.00
PHR.LS cash_flow (annual, 2023-12-31) — Purchase Of PPE: -7414.00
PHR.LS income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 310152.00
PHR.LS income_statement (annual, 2023-12-31) — Reconciled Depreciation: 40338.00
PHR.LS cash_flow (annual, 2023-12-31) — Repayment Of Debt: 0.00
PHR.LS balance_sheet (annual, 2023-12-31) — Retained Earnings: 110945176.00
PHR.LS cash_flow (annual, 2023-12-31) — Sale Of Investment: 3195334.00
PHR.LS cash_flow (annual, 2023-12-31) — Sale Of PPE: 0.00
PHR.LS income_statement (annual, 2023-12-31) — Selling General And Administration: 274495.00
PHR.LS balance_sheet (annual, 2023-12-31) — Share Issued: 896512500.00
PHR.LS income_statement (annual, 2023-12-31) — Special Income Charges: 1132854.00
PHR.LS balance_sheet (annual, 2023-12-31) — Stockholders Equity: 68136817.00
PHR.LS balance_sheet (annual, 2023-12-31) — Tangible Book Value: 68136817.00
PHR.LS income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 237899.34
PHR.LS income_statement (annual, 2023-12-31) — Tax Provision: 24623.00
PHR.LS income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.21
PHR.LS balance_sheet (annual, 2023-12-31) — Taxes Receivable: 61485.00
PHR.LS cash_flow (annual, 2023-12-31) — Taxes Refund Paid Direct: -44108.00
PHR.LS balance_sheet (annual, 2023-12-31) — Total Assets: 95423958.00
PHR.LS balance_sheet (annual, 2023-12-31) — Total Capitalization: 68186688.00
PHR.LS balance_sheet (annual, 2023-12-31) — Total Debt: 49871.00
PHR.LS balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 68136817.00
PHR.LS income_statement (annual, 2023-12-31) — Total Expenses: 2261595.00
PHR.LS balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 27287141.00
PHR.LS balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 77895227.00
PHR.LS balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 125646.00
PHR.LS income_statement (annual, 2023-12-31) — Total Other Finance Cost: 16370.00
PHR.LS balance_sheet (annual, 2023-12-31) — Total Tax Payable: 131035.00
PHR.LS income_statement (annual, 2023-12-31) — Total Unusual Items: 1132854.00
PHR.LS income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 1132854.00
PHR.LS balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 74689552.00
PHR.LS balance_sheet (annual, 2023-12-31) — Treasury Stock: 164809193.00
PHR.LS balance_sheet (annual, 2023-12-31) — Working Capital: -9632764.00
PHR.LS income_statement (annual, 2024-12-31) — +Operating Expense: 2408339.00
PHR.LS income_statement (annual, 2024-12-31) — +Total Revenue: 0.00
PHR.LS balance_sheet (annual, 2024-12-31) — Accounts Payable: 24349.00
PHR.LS balance_sheet (quarterly, 2024-12-31) — Accounts Payable: 24349.00
PHR.LS balance_sheet (annual, 2024-12-31) — Accounts Receivable: 150357.00
PHR.LS balance_sheet (quarterly, 2024-12-31) — Accounts Receivable: 150357.00
PHR.LS balance_sheet (annual, 2024-12-31) — Available For Sale Securities: 12362.00
PHR.LS balance_sheet (quarterly, 2024-12-31) — Available For Sale Securities: 12362.00
PHR.LS income_statement (annual, 2024-12-31) — Basic Average Shares: 821756654.00
PHR.LS income_statement (annual, 2024-12-31) — Basic EPS: 0.03
PHR.LS cash_flow (annual, 2024-12-31) — Beginning Cash Position: 17196818.00
PHR.LS cash_flow (annual, 2024-12-31) — Capital Expenditure: -21849.00
PHR.LS balance_sheet (annual, 2024-12-31) — Capital Stock: 26895375.00
PHR.LS balance_sheet (quarterly, 2024-12-31) — Capital Stock: 26895375.00
PHR.LS balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 15961453.00
PHR.LS balance_sheet (quarterly, 2024-12-31) — Cash And Cash Equivalents: 15961453.00
PHR.LS balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 15961453.00
PHR.LS balance_sheet (quarterly, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 15961453.00
PHR.LS cash_flow (annual, 2024-12-31) — Cash Flowsfromusedin Operating Activities Direct: -1740285.00
PHR.LS cash_flow (annual, 2024-12-31) — Changes In Cash: -1210385.00
PHR.LS cash_flow (annual, 2024-12-31) — Classesof Cash Payments: -1967592.00
PHR.LS cash_flow (annual, 2024-12-31) — Classesof Cash Receiptsfrom Operating Activities: 343694.00
PHR.LS balance_sheet (annual, 2024-12-31) — Common Stock: 26895375.00
PHR.LS balance_sheet (quarterly, 2024-12-31) — Common Stock: 26895375.00
PHR.LS balance_sheet (annual, 2024-12-31) — Common Stock Equity: 92201331.00
PHR.LS balance_sheet (quarterly, 2024-12-31) — Common Stock Equity: 92201331.00
PHR.LS balance_sheet (annual, 2024-12-31) — Current Assets: 16115049.00
PHR.LS balance_sheet (quarterly, 2024-12-31) — Current Assets: 16115049.00
PHR.LS balance_sheet (annual, 2024-12-31) — Current Deferred Assets: 3239.00
PHR.LS balance_sheet (quarterly, 2024-12-31) — Current Deferred Assets: 3239.00
PHR.LS balance_sheet (annual, 2024-12-31) — Current Liabilities: 2748606.00
PHR.LS balance_sheet (quarterly, 2024-12-31) — Current Liabilities: 2748606.00
PHR.LS income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 14653.00
PHR.LS income_statement (annual, 2024-12-31) — Depreciation Income Statement: 14653.00
PHR.LS income_statement (annual, 2024-12-31) — Diluted Average Shares: 821756654.00
PHR.LS income_statement (annual, 2024-12-31) — Diluted EPS: 0.03
PHR.LS income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 24224749.00
PHR.LS income_statement (annual, 2024-12-31) — EBIT: -2408339.00
PHR.LS income_statement (annual, 2024-12-31) — EBITDA: -2393686.00
PHR.LS cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -24981.00
PHR.LS cash_flow (annual, 2024-12-31) — End Cash Position: 15961453.00
PHR.LS balance_sheet (annual, 2024-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 26979396.00
PHR.LS balance_sheet (quarterly, 2024-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 26979396.00
PHR.LS cash_flow (annual, 2024-12-31) — Financing Cash Flow: -1926.00
PHR.LS cash_flow (annual, 2024-12-31) — Free Cash Flow: -1762134.00
PHR.LS income_statement (annual, 2024-12-31) — General And Administrative Expense: 228203.00
PHR.LS income_statement (annual, 2024-12-31) — Interest Income: 399492.00
PHR.LS income_statement (annual, 2024-12-31) — Interest Income Non Operating: 399492.00
PHR.LS cash_flow (annual, 2024-12-31) — Interest Paid Cff: -1926.00
PHR.LS cash_flow (annual, 2024-12-31) — Interest Received Cfi: 414156.00
PHR.LS balance_sheet (annual, 2024-12-31) — Invested Capital: 92208778.00
PHR.LS balance_sheet (quarterly, 2024-12-31) — Invested Capital: 92208778.00
PHR.LS cash_flow (annual, 2024-12-31) — Investing Cash Flow: 531826.00
PHR.LS balance_sheet (annual, 2024-12-31) — Investmentin Financial Assets: 26991758.00
PHR.LS balance_sheet (quarterly, 2024-12-31) — Investmentin Financial Assets: 26991758.00
PHR.LS balance_sheet (annual, 2024-12-31) — Long Term Debt: 7447.00
PHR.LS balance_sheet (quarterly, 2024-12-31) — Long Term Debt: 7447.00
PHR.LS balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 7447.00
PHR.LS balance_sheet (quarterly, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 7447.00
PHR.LS balance_sheet (annual, 2024-12-31) — Long Term Provisions: 75775.00
PHR.LS balance_sheet (quarterly, 2024-12-31) — Long Term Provisions: 75775.00
PHR.LS income_statement (annual, 2024-12-31) — Net Income: 24224749.00
PHR.LS income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 24224749.00
PHR.LS income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 24224749.00
PHR.LS income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 24224749.00
PHR.LS income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 24224749.00
PHR.LS income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 24224749.00
PHR.LS income_statement (annual, 2024-12-31) — Net Interest Income: 399492.00
PHR.LS cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 133916.00
PHR.LS income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 399492.00
PHR.LS balance_sheet (annual, 2024-12-31) — Net PPE: 19882.00
PHR.LS balance_sheet (quarterly, 2024-12-31) — Net PPE: 19882.00
PHR.LS cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -16246.00
PHR.LS balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 92201331.00
PHR.LS balance_sheet (quarterly, 2024-12-31) — Net Tangible Assets: 92201331.00
PHR.LS income_statement (annual, 2024-12-31) — Normalized EBITDA: -3792534.00
PHR.LS income_statement (annual, 2024-12-31) — Normalized Income: 22894586.99
PHR.LS income_statement (annual, 2024-12-31) — Operating Income: -2408339.00
PHR.LS income_statement (annual, 2024-12-31) — Operating Revenue: 0.00
PHR.LS balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 821822948.00
PHR.LS balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 821822948.00
PHR.LS cash_flow (annual, 2024-12-31) — Other Cash Adjustment Outside Changein Cash: 1.00
PHR.LS cash_flow (annual, 2024-12-31) — Other Cash Receiptsfrom Operating Activities: 343694.00
PHR.LS balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 856550.00
PHR.LS balance_sheet (quarterly, 2024-12-31) — Other Current Liabilities: 856550.00
PHR.LS balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 51906470.00
PHR.LS balance_sheet (quarterly, 2024-12-31) — Other Non Current Assets: 51906470.00
PHR.LS income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 26106799.00
PHR.LS income_statement (annual, 2024-12-31) — Other Operating Expenses: 1174453.00
PHR.LS balance_sheet (annual, 2024-12-31) — Other Payable: 64963.00
PHR.LS balance_sheet (quarterly, 2024-12-31) — Other Payable: 64963.00
PHR.LS income_statement (annual, 2024-12-31) — Other Special Charges: -1399193.00
PHR.LS income_statement (annual, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
PHR.LS balance_sheet (annual, 2024-12-31) — Payables: 1278723.00
PHR.LS balance_sheet (quarterly, 2024-12-31) — Payables: 1278723.00
PHR.LS cash_flow (annual, 2024-12-31) — Paymentson Behalfof Employees: -791815.00
PHR.LS cash_flow (annual, 2024-12-31) — Paymentsto Suppliersfor Goodsand Services: -1175777.00
PHR.LS balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 430505.00
PHR.LS balance_sheet (quarterly, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 430505.00
PHR.LS income_statement (annual, 2024-12-31) — Pretax Income: 25475650.00
PHR.LS cash_flow (annual, 2024-12-31) — Purchase Of Investment: 0.00
PHR.LS cash_flow (annual, 2024-12-31) — Purchase Of PPE: -21849.00
PHR.LS income_statement (annual, 2024-12-31) — Reconciled Depreciation: 14653.00
PHR.LS cash_flow (annual, 2024-12-31) — Sale Of Investment: 133916.00
PHR.LS cash_flow (annual, 2024-12-31) — Sale Of PPE: 5603.00
PHR.LS income_statement (annual, 2024-12-31) — Selling General And Administration: 228203.00
PHR.LS balance_sheet (annual, 2024-12-31) — Share Issued: 896512500.00
PHR.LS balance_sheet (quarterly, 2024-12-31) — Share Issued: 896512500.00
PHR.LS income_statement (annual, 2024-12-31) — Special Income Charges: 1399193.00
PHR.LS balance_sheet (annual, 2024-12-31) — Stockholders Equity: 92201331.00
PHR.LS balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: 92201331.00
PHR.LS balance_sheet (annual, 2024-12-31) — Tangible Book Value: 92201331.00
PHR.LS balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: 92201331.00
PHR.LS income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 68685.99
PHR.LS income_statement (annual, 2024-12-31) — Tax Provision: 1250901.00
PHR.LS income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.05
PHR.LS balance_sheet (annual, 2024-12-31) — Taxes Receivable: 0.00
PHR.LS balance_sheet (quarterly, 2024-12-31) — Taxes Receivable: 0.00
PHR.LS cash_flow (annual, 2024-12-31) — Taxes Refund Paid Direct: -116387.00
PHR.LS balance_sheet (annual, 2024-12-31) — Total Assets: 95033159.00
PHR.LS balance_sheet (quarterly, 2024-12-31) — Total Assets: 95033159.00
PHR.LS balance_sheet (annual, 2024-12-31) — Total Capitalization: 92208778.00
PHR.LS balance_sheet (quarterly, 2024-12-31) — Total Capitalization: 92208778.00
PHR.LS balance_sheet (annual, 2024-12-31) — Total Debt: 7447.00
PHR.LS balance_sheet (quarterly, 2024-12-31) — Total Debt: 7447.00
PHR.LS balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 92201331.00
PHR.LS balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: 92201331.00
PHR.LS income_statement (annual, 2024-12-31) — Total Expenses: 2408339.00
PHR.LS balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 2831828.00
PHR.LS balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 2831828.00
PHR.LS balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 78918110.00
PHR.LS balance_sheet (quarterly, 2024-12-31) — Total Non Current Assets: 78918110.00
PHR.LS balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 83222.00
PHR.LS balance_sheet (quarterly, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 83222.00
PHR.LS income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 23701490.00
PHR.LS income_statement (annual, 2024-12-31) — Total Other Finance Cost: 3030.00
PHR.LS balance_sheet (annual, 2024-12-31) — Total Tax Payable: 1189411.00
PHR.LS balance_sheet (quarterly, 2024-12-31) — Total Tax Payable: 1189411.00
PHR.LS income_statement (annual, 2024-12-31) — Total Unusual Items: 1398848.00
PHR.LS income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 1398848.00
PHR.LS balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 74689552.00
PHR.LS balance_sheet (quarterly, 2024-12-31) — Treasury Shares Number: 74689552.00
PHR.LS balance_sheet (annual, 2024-12-31) — Treasury Stock: 164809193.00
PHR.LS balance_sheet (quarterly, 2024-12-31) — Treasury Stock: 164809193.00
PHR.LS balance_sheet (annual, 2024-12-31) — Working Capital: 13366443.00
PHR.LS balance_sheet (quarterly, 2024-12-31) — Working Capital: 13366443.00
PHR.LS balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 23999.00
PHR.LS balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 532785.00
PHR.LS balance_sheet (quarterly, 2025-06-30) — Capital Stock: 26895375.00
PHR.LS balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 15488021.00
PHR.LS balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 15488021.00
PHR.LS balance_sheet (quarterly, 2025-06-30) — Cash Equivalents: 14586574.00
PHR.LS balance_sheet (quarterly, 2025-06-30) — Cash Financial: 901447.00
PHR.LS balance_sheet (quarterly, 2025-06-30) — Common Stock: 26895375.00
PHR.LS balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 94291103.00
PHR.LS balance_sheet (quarterly, 2025-06-30) — Current Assets: 16251806.00
PHR.LS balance_sheet (quarterly, 2025-06-30) — Current Deferred Assets: 100432.00
PHR.LS balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 1226047.00
PHR.LS balance_sheet (quarterly, 2025-06-30) — Invested Capital: 94310915.00
PHR.LS balance_sheet (quarterly, 2025-06-30) — Investmentin Financial Assets: 27375085.00
PHR.LS balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 19812.00
PHR.LS balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 19812.00
PHR.LS balance_sheet (quarterly, 2025-06-30) — Long Term Provisions: 81117.00
PHR.LS balance_sheet (quarterly, 2025-06-30) — Net PPE: 84718.00
PHR.LS balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 94291103.00
PHR.LS balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 821822948.00
PHR.LS balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 856549.00
PHR.LS balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 51906470.00
PHR.LS balance_sheet (quarterly, 2025-06-30) — Other Payable: 27724.00
PHR.LS balance_sheet (quarterly, 2025-06-30) — Payables: 120787.00
PHR.LS balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 163265.00
PHR.LS balance_sheet (quarterly, 2025-06-30) — Share Issued: 821822948.00
PHR.LS balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 94291103.00
PHR.LS balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 94291103.00
PHR.LS balance_sheet (quarterly, 2025-06-30) — Taxes Receivable: 130568.00
PHR.LS balance_sheet (quarterly, 2025-06-30) — Total Assets: 95618079.00
PHR.LS balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 94310915.00
PHR.LS balance_sheet (quarterly, 2025-06-30) — Total Debt: 19812.00
PHR.LS balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 94291103.00
PHR.LS balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 1326976.00
PHR.LS balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 79366273.00
PHR.LS balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 100929.00
PHR.LS balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 69064.00
PHR.LS balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 164809193.00
PHR.LS balance_sheet (quarterly, 2025-06-30) — Working Capital: 15025759.00
PHR.LS income_statement (annual, 2025-12-31) — +Operating Expense: 2517223.00
PHR.LS income_statement (annual, 2025-12-31) — +Total Revenue: 0.00
PHR.LS balance_sheet (annual, 2025-12-31) — Accounts Payable: 24359.00
PHR.LS balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 24359.00
PHR.LS balance_sheet (annual, 2025-12-31) — Accounts Receivable: 803899.00
PHR.LS balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 803899.00
PHR.LS income_statement (annual, 2025-12-31) — Basic Average Shares: 821756654.00
PHR.LS income_statement (annual, 2025-12-31) — Basic EPS: 0.00
PHR.LS cash_flow (annual, 2025-12-31) — Beginning Cash Position: 15961453.00
PHR.LS cash_flow (annual, 2025-12-31) — Capital Expenditure: -128733.00
PHR.LS balance_sheet (annual, 2025-12-31) — Capital Stock: 26895375.00
PHR.LS balance_sheet (quarterly, 2025-12-31) — Capital Stock: 26895375.00
PHR.LS balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 14972647.00
PHR.LS balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 14972647.00
PHR.LS balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 14972647.00
PHR.LS balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 14972647.00
PHR.LS cash_flow (annual, 2025-12-31) — Cash Flowsfromusedin Operating Activities Direct: -1102851.00
PHR.LS cash_flow (annual, 2025-12-31) — Changes In Cash: -988891.00
PHR.LS cash_flow (annual, 2025-12-31) — Classesof Cash Payments: -2220342.00
PHR.LS cash_flow (annual, 2025-12-31) — Classesof Cash Receiptsfrom Operating Activities: 2902327.00
PHR.LS balance_sheet (annual, 2025-12-31) — Common Stock: 26895375.00
PHR.LS balance_sheet (quarterly, 2025-12-31) — Common Stock: 26895375.00
PHR.LS balance_sheet (annual, 2025-12-31) — Common Stock Equity: 94280806.00
PHR.LS balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 94280806.00
PHR.LS balance_sheet (annual, 2025-12-31) — Current Assets: 16493111.00
PHR.LS balance_sheet (quarterly, 2025-12-31) — Current Assets: 16493111.00
PHR.LS balance_sheet (annual, 2025-12-31) — Current Deferred Assets: 10575.00
PHR.LS balance_sheet (quarterly, 2025-12-31) — Current Deferred Assets: 10575.00
PHR.LS balance_sheet (annual, 2025-12-31) — Current Liabilities: 1963404.00
PHR.LS balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 1963404.00
PHR.LS income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 29616.00
PHR.LS income_statement (annual, 2025-12-31) — Depreciation Income Statement: 29616.00
PHR.LS income_statement (annual, 2025-12-31) — Diluted Average Shares: 821756654.00
PHR.LS income_statement (annual, 2025-12-31) — Diluted EPS: 0.00
PHR.LS income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 2100757.00
PHR.LS income_statement (annual, 2025-12-31) — EBIT: -2517223.00
PHR.LS income_statement (annual, 2025-12-31) — EBITDA: -2487607.00
PHR.LS cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 85.00
PHR.LS cash_flow (annual, 2025-12-31) — End Cash Position: 14972647.00
PHR.LS balance_sheet (annual, 2025-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 27758393.00
PHR.LS balance_sheet (quarterly, 2025-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 27758393.00
PHR.LS cash_flow (annual, 2025-12-31) — Financing Cash Flow: -1318.00
PHR.LS cash_flow (annual, 2025-12-31) — Free Cash Flow: -1231584.00
PHR.LS income_statement (annual, 2025-12-31) — General And Administrative Expense: 208129.00
PHR.LS income_statement (annual, 2025-12-31) — Interest Income: 234016.00
PHR.LS income_statement (annual, 2025-12-31) — Interest Income Non Operating: 234016.00
PHR.LS cash_flow (annual, 2025-12-31) — Interest Paid Cff: -1318.00
PHR.LS cash_flow (annual, 2025-12-31) — Interest Received Cfi: 244038.00
PHR.LS balance_sheet (annual, 2025-12-31) — Invested Capital: 94281619.00
PHR.LS balance_sheet (quarterly, 2025-12-31) — Invested Capital: 94281619.00
PHR.LS cash_flow (annual, 2025-12-31) — Investing Cash Flow: 115278.00
PHR.LS balance_sheet (annual, 2025-12-31) — Investmentin Financial Assets: 27758393.00
PHR.LS balance_sheet (quarterly, 2025-12-31) — Investmentin Financial Assets: 27758393.00
PHR.LS balance_sheet (annual, 2025-12-31) — Long Term Debt: 813.00
PHR.LS balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 813.00
PHR.LS balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 813.00
PHR.LS balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 813.00
PHR.LS balance_sheet (annual, 2025-12-31) — Long Term Provisions: 75775.00
PHR.LS balance_sheet (quarterly, 2025-12-31) — Long Term Provisions: 75775.00
PHR.LS income_statement (annual, 2025-12-31) — Net Income: 2100757.00
PHR.LS income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 2100757.00
PHR.LS income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 2100757.00
PHR.LS income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 2100757.00
PHR.LS income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 2100757.00
PHR.LS income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 2100757.00
PHR.LS income_statement (annual, 2025-12-31) — Net Interest Income: 234016.00
PHR.LS cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -26.00
PHR.LS income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 234016.00
PHR.LS cash_flow (annual, 2025-12-31) — Net Other Investing Changes: -1.00
PHR.LS balance_sheet (annual, 2025-12-31) — Net PPE: 162823.00
PHR.LS balance_sheet (quarterly, 2025-12-31) — Net PPE: 162823.00
PHR.LS cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -128733.00
PHR.LS balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 94280806.00
PHR.LS balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 94280806.00
PHR.LS income_statement (annual, 2025-12-31) — Normalized EBITDA: -3320593.00
PHR.LS income_statement (annual, 2025-12-31) — Normalized Income: 1287324.30
PHR.LS income_statement (annual, 2025-12-31) — Operating Income: -2517223.00
PHR.LS income_statement (annual, 2025-12-31) — Operating Revenue: 0.00
PHR.LS balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 821822948.00
PHR.LS balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 821822948.00
PHR.LS cash_flow (annual, 2025-12-31) — Other Cash Receiptsfrom Operating Activities: 2902327.00
PHR.LS balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 856549.00
PHR.LS balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 856549.00
PHR.LS balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 51906470.00
PHR.LS balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 51906470.00
PHR.LS income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 3586483.00
PHR.LS income_statement (annual, 2025-12-31) — Other Operating Expenses: 1080655.00
PHR.LS balance_sheet (annual, 2025-12-31) — Other Payable: 238769.00
PHR.LS balance_sheet (quarterly, 2025-12-31) — Other Payable: 238769.00
PHR.LS income_statement (annual, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
PHR.LS balance_sheet (annual, 2025-12-31) — Payables: 390865.00
PHR.LS balance_sheet (quarterly, 2025-12-31) — Payables: 390865.00
PHR.LS cash_flow (annual, 2025-12-31) — Paymentson Behalfof Employees: -1226828.00
PHR.LS cash_flow (annual, 2025-12-31) — Paymentsto Suppliersfor Goodsand Services: -993514.00
PHR.LS balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 419541.00
PHR.LS balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 419541.00
PHR.LS income_statement (annual, 2025-12-31) — Pretax Income: 2151255.00
PHR.LS cash_flow (annual, 2025-12-31) — Purchase Of Investment: -26.00
PHR.LS cash_flow (annual, 2025-12-31) — Purchase Of PPE: -128733.00
PHR.LS income_statement (annual, 2025-12-31) — Reconciled Depreciation: 29616.00
PHR.LS cash_flow (annual, 2025-12-31) — Sale Of PPE: 0.00
PHR.LS income_statement (annual, 2025-12-31) — Selling General And Administration: 208129.00
PHR.LS balance_sheet (annual, 2025-12-31) — Share Issued: 896512500.00
PHR.LS balance_sheet (quarterly, 2025-12-31) — Share Issued: 896512500.00
PHR.LS balance_sheet (annual, 2025-12-31) — Stockholders Equity: 94280806.00
PHR.LS balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 94280806.00
PHR.LS balance_sheet (annual, 2025-12-31) — Tangible Book Value: 94280806.00
PHR.LS balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 94280806.00
PHR.LS income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 19553.30
PHR.LS income_statement (annual, 2025-12-31) — Tax Provision: 50498.00
PHR.LS income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.02
PHR.LS balance_sheet (annual, 2025-12-31) — Taxes Receivable: 705990.00
PHR.LS balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 705990.00
PHR.LS cash_flow (annual, 2025-12-31) — Taxes Refund Paid Direct: -1784836.00
PHR.LS balance_sheet (annual, 2025-12-31) — Total Assets: 96320798.00
PHR.LS balance_sheet (quarterly, 2025-12-31) — Total Assets: 96320798.00
PHR.LS balance_sheet (annual, 2025-12-31) — Total Capitalization: 94281619.00
PHR.LS balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 94281619.00
PHR.LS balance_sheet (annual, 2025-12-31) — Total Debt: 813.00
PHR.LS balance_sheet (quarterly, 2025-12-31) — Total Debt: 813.00
PHR.LS balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 94280806.00
PHR.LS balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 94280806.00
PHR.LS income_statement (annual, 2025-12-31) — Total Expenses: 2517223.00
PHR.LS balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 2039992.00
PHR.LS balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 2039992.00
PHR.LS balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 79827686.00
PHR.LS balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 79827686.00
PHR.LS balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 76588.00
PHR.LS balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 76588.00
PHR.LS income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 1080423.00
PHR.LS balance_sheet (annual, 2025-12-31) — Total Tax Payable: 127737.00
PHR.LS balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 127737.00
PHR.LS income_statement (annual, 2025-12-31) — Total Unusual Items: 832986.00
PHR.LS income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 832986.00
PHR.LS balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 74689552.00
PHR.LS balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 74689552.00
PHR.LS balance_sheet (annual, 2025-12-31) — Treasury Stock: 164809193.00
PHR.LS balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 164809193.00
PHR.LS balance_sheet (annual, 2025-12-31) — Working Capital: 14529707.00
PHR.LS balance_sheet (quarterly, 2025-12-31) — Working Capital: 14529707.00
PHSC.L income_statement (annual, 2022-03-31) — +Operating Expense: 1416524.00
PHSC.L income_statement (annual, 2022-03-31) — +Total Revenue: 3570626.00
PHSC.L balance_sheet (annual, 2022-03-31) — Accounts Payable: 134316.00
PHSC.L balance_sheet (annual, 2022-03-31) — Accounts Receivable: 628132.00
PHSC.L balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -438459.00
PHSC.L balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 2059645.00
PHSC.L balance_sheet (annual, 2022-03-31) — Allowance For Doubtful Accounts Receivable: -2485.00
PHSC.L income_statement (annual, 2022-03-31) — Basic Average Shares: 13256366.00
PHSC.L income_statement (annual, 2022-03-31) — Basic EPS: -0.05
PHSC.L cash_flow (annual, 2022-03-31) — Beginning Cash Position: 1237483.00
PHSC.L cash_flow (annual, 2022-03-31) — Capital Expenditure: -22117.00
PHSC.L balance_sheet (annual, 2022-03-31) — Capital Lease Obligations: 54816.00
PHSC.L balance_sheet (annual, 2022-03-31) — Capital Stock: 1467726.00
PHSC.L balance_sheet (annual, 2022-03-31) — Cash And Cash Equivalents: 649363.00
PHSC.L balance_sheet (annual, 2022-03-31) — Cash Cash Equivalents And Short Term Investments: 649363.00
PHSC.L cash_flow (annual, 2022-03-31) — Cash Dividends Paid: -130205.00
PHSC.L balance_sheet (annual, 2022-03-31) — Cash Financial: 649363.00
PHSC.L cash_flow (annual, 2022-03-31) — Change In Inventory: 74075.00
PHSC.L cash_flow (annual, 2022-03-31) — Change In Payable: 98832.00
PHSC.L cash_flow (annual, 2022-03-31) — Change In Receivables: -136250.00
PHSC.L cash_flow (annual, 2022-03-31) — Change In Working Capital: 36657.00
PHSC.L cash_flow (annual, 2022-03-31) — Changes In Cash: -588120.00
PHSC.L balance_sheet (annual, 2022-03-31) — Common Stock: 1467726.00
PHSC.L cash_flow (annual, 2022-03-31) — Common Stock Dividend Paid: -130205.00
PHSC.L balance_sheet (annual, 2022-03-31) — Common Stock Equity: 3513353.00
PHSC.L cash_flow (annual, 2022-03-31) — Common Stock Payments: -644738.00
PHSC.L income_statement (annual, 2022-03-31) — Cost Of Revenue: 1938870.00
PHSC.L balance_sheet (annual, 2022-03-31) — Current Assets: 1561426.00
PHSC.L balance_sheet (annual, 2022-03-31) — Current Capital Lease Obligation: 30632.00
PHSC.L balance_sheet (annual, 2022-03-31) — Current Debt And Capital Lease Obligation: 30632.00
PHSC.L balance_sheet (annual, 2022-03-31) — Current Liabilities: 702821.00
PHSC.L cash_flow (annual, 2022-03-31) — Depreciation: 58812.00
PHSC.L cash_flow (annual, 2022-03-31) — Depreciation And Amortization: 58812.00
PHSC.L income_statement (annual, 2022-03-31) — Depreciation And Amortization In Income Statement: 58812.00
PHSC.L income_statement (annual, 2022-03-31) — Depreciation Income Statement: 58812.00
PHSC.L income_statement (annual, 2022-03-31) — Diluted Average Shares: 13256366.00
PHSC.L income_statement (annual, 2022-03-31) — Diluted EPS: -0.05
PHSC.L income_statement (annual, 2022-03-31) — Diluted NI Availto Com Stockholders: -631003.00
PHSC.L income_statement (annual, 2022-03-31) — EBIT: 215232.00
PHSC.L income_statement (annual, 2022-03-31) — EBITDA: 274044.00
PHSC.L cash_flow (annual, 2022-03-31) — End Cash Position: 649363.00
PHSC.L cash_flow (annual, 2022-03-31) — Financing Cash Flow: -790848.00
PHSC.L balance_sheet (annual, 2022-03-31) — Finished Goods: 243249.00
PHSC.L cash_flow (annual, 2022-03-31) — Free Cash Flow: 202200.00
PHSC.L cash_flow (annual, 2022-03-31) — Gain Loss On Sale Of PPE: 2441.00
PHSC.L income_statement (annual, 2022-03-31) — General And Administrative Expense: 1446051.00
PHSC.L balance_sheet (annual, 2022-03-31) — Goodwill: 2235045.00
PHSC.L balance_sheet (annual, 2022-03-31) — Goodwill And Other Intangible Assets: 2235045.00
PHSC.L balance_sheet (annual, 2022-03-31) — Gross Accounts Receivable: 630617.00
PHSC.L balance_sheet (annual, 2022-03-31) — Gross PPE: 928597.00
PHSC.L income_statement (annual, 2022-03-31) — Gross Profit: 1631756.00
PHSC.L income_statement (annual, 2022-03-31) — Interest Income: 388.00
PHSC.L income_statement (annual, 2022-03-31) — Interest Income Non Operating: 388.00
PHSC.L cash_flow (annual, 2022-03-31) — Interest Received Cfi: 388.00
PHSC.L balance_sheet (annual, 2022-03-31) — Inventories Adjustments Allowances: -57564.00
PHSC.L balance_sheet (annual, 2022-03-31) — Inventory: 185685.00
PHSC.L balance_sheet (annual, 2022-03-31) — Invested Capital: 3513353.00
PHSC.L cash_flow (annual, 2022-03-31) — Investing Cash Flow: -21589.00
PHSC.L balance_sheet (annual, 2022-03-31) — Long Term Capital Lease Obligation: 24184.00
PHSC.L balance_sheet (annual, 2022-03-31) — Long Term Debt And Capital Lease Obligation: 24184.00
PHSC.L balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 123445.00
PHSC.L cash_flow (annual, 2022-03-31) — Net Common Stock Issuance: -644738.00
PHSC.L income_statement (annual, 2022-03-31) — Net Income: -631003.00
PHSC.L income_statement (annual, 2022-03-31) — Net Income Common Stockholders: -631003.00
PHSC.L income_statement (annual, 2022-03-31) — Net Income Continuous Operations: -631003.00
PHSC.L income_statement (annual, 2022-03-31) — Net Income From Continuing And Discontinued Operation: -631003.00
PHSC.L income_statement (annual, 2022-03-31) — Net Income From Continuing Operation Net Minority Interest: -631003.00
PHSC.L cash_flow (annual, 2022-03-31) — Net Income From Continuing Operations: -577798.00
PHSC.L income_statement (annual, 2022-03-31) — Net Income Including Noncontrolling Interests: -631003.00
PHSC.L income_statement (annual, 2022-03-31) — Net Interest Income: 388.00
PHSC.L income_statement (annual, 2022-03-31) — Net Non Operating Interest Income Expense: 388.00
PHSC.L balance_sheet (annual, 2022-03-31) — Net PPE: 490138.00
PHSC.L cash_flow (annual, 2022-03-31) — Net PPE Purchase And Sale: -21977.00
PHSC.L balance_sheet (annual, 2022-03-31) — Net Tangible Assets: 1278308.00
PHSC.L balance_sheet (annual, 2022-03-31) — Non Current Deferred Taxes Assets: 15591.00
PHSC.L balance_sheet (annual, 2022-03-31) — Non Current Deferred Taxes Liabilities: 61842.00
PHSC.L income_statement (annual, 2022-03-31) — Normalized EBITDA: 274044.00
PHSC.L income_statement (annual, 2022-03-31) — Normalized Income: 805083.58
PHSC.L cash_flow (annual, 2022-03-31) — Operating Cash Flow: 224317.00
PHSC.L income_statement (annual, 2022-03-31) — Operating Income: 215232.00
PHSC.L income_statement (annual, 2022-03-31) — Operating Revenue: 3570626.00
PHSC.L balance_sheet (annual, 2022-03-31) — Ordinary Shares Number: 11847019.00
PHSC.L balance_sheet (annual, 2022-03-31) — Other Payable: 8830.00
PHSC.L balance_sheet (annual, 2022-03-31) — Other Properties: 233882.00
PHSC.L balance_sheet (annual, 2022-03-31) — Other Receivables: 96841.00
PHSC.L income_statement (annual, 2022-03-31) — Otherunder Preferred Stock Dividend: 0.00
PHSC.L balance_sheet (annual, 2022-03-31) — Payables: 370083.00
PHSC.L income_statement (annual, 2022-03-31) — Pretax Income: -577798.00
PHSC.L balance_sheet (annual, 2022-03-31) — Properties: 571270.00
PHSC.L cash_flow (annual, 2022-03-31) — Purchase Of PPE: -22117.00
PHSC.L income_statement (annual, 2022-03-31) — Reconciled Cost Of Revenue: 1938870.00
PHSC.L income_statement (annual, 2022-03-31) — Reconciled Depreciation: 58812.00
PHSC.L cash_flow (annual, 2022-03-31) — Repurchase Of Capital Stock: -644738.00
PHSC.L balance_sheet (annual, 2022-03-31) — Retained Earnings: 496884.00
PHSC.L cash_flow (annual, 2022-03-31) — Sale Of PPE: 140.00
PHSC.L income_statement (annual, 2022-03-31) — Selling General And Administration: 1446051.00
PHSC.L balance_sheet (annual, 2022-03-31) — Share Issued: 14677257.00
PHSC.L income_statement (annual, 2022-03-31) — Special Income Charges: -793418.00
PHSC.L balance_sheet (annual, 2022-03-31) — Stockholders Equity: 3513353.00
PHSC.L balance_sheet (annual, 2022-03-31) — Tangible Book Value: 1278308.00
PHSC.L income_statement (annual, 2022-03-31) — Tax Effect Of Unusual Items: -150749.42
PHSC.L income_statement (annual, 2022-03-31) — Tax Provision: 53205.00
PHSC.L income_statement (annual, 2022-03-31) — Tax Rate For Calcs: 0.19
PHSC.L balance_sheet (annual, 2022-03-31) — Taxes Receivable: 1405.00
PHSC.L cash_flow (annual, 2022-03-31) — Taxes Refund Paid: -89213.00
PHSC.L balance_sheet (annual, 2022-03-31) — Total Assets: 4302200.00
PHSC.L balance_sheet (annual, 2022-03-31) — Total Capitalization: 3513353.00
PHSC.L balance_sheet (annual, 2022-03-31) — Total Debt: 54816.00
PHSC.L balance_sheet (annual, 2022-03-31) — Total Equity Gross Minority Interest: 3513353.00
PHSC.L income_statement (annual, 2022-03-31) — Total Expenses: 3355394.00
PHSC.L balance_sheet (annual, 2022-03-31) — Total Liabilities Net Minority Interest: 788847.00
PHSC.L balance_sheet (annual, 2022-03-31) — Total Non Current Assets: 2740774.00
PHSC.L balance_sheet (annual, 2022-03-31) — Total Non Current Liabilities Net Minority Interest: 86026.00
PHSC.L income_statement (annual, 2022-03-31) — Total Operating Income As Reported: -578186.00
PHSC.L balance_sheet (annual, 2022-03-31) — Total Tax Payable: 226937.00
PHSC.L income_statement (annual, 2022-03-31) — Total Unusual Items: 0.00
PHSC.L income_statement (annual, 2022-03-31) — Total Unusual Items Excluding Goodwill: -793418.00
PHSC.L balance_sheet (annual, 2022-03-31) — Treasury Shares Number: 2830238.00
PHSC.L balance_sheet (annual, 2022-03-31) — Treasury Stock: 644738.00
PHSC.L balance_sheet (annual, 2022-03-31) — Working Capital: 858605.00
PHSC.L income_statement (annual, 2023-03-31) — +Operating Expense: 1521829.00
PHSC.L income_statement (annual, 2023-03-31) — +Total Revenue: 3437624.00
PHSC.L balance_sheet (annual, 2023-03-31) — Accounts Payable: 48267.00
PHSC.L balance_sheet (annual, 2023-03-31) — Accounts Receivable: 580845.00
PHSC.L balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -501493.00
PHSC.L balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 2342667.00
PHSC.L balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: 0.00
PHSC.L income_statement (annual, 2023-03-31) — Basic Average Shares: 11847019.00
PHSC.L income_statement (annual, 2023-03-31) — Basic EPS: 2.05
PHSC.L cash_flow (annual, 2023-03-31) — Beginning Cash Position: 649363.00
PHSC.L cash_flow (annual, 2023-03-31) — Capital Expenditure: -41386.00
PHSC.L balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 50551.00
PHSC.L balance_sheet (annual, 2023-03-31) — Capital Stock: 1184704.00
PHSC.L balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 749627.00
PHSC.L balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 749627.00
PHSC.L cash_flow (annual, 2023-03-31) — Cash Dividends Paid: -118470.00
PHSC.L balance_sheet (annual, 2023-03-31) — Cash Financial: 749627.00
PHSC.L cash_flow (annual, 2023-03-31) — Change In Inventory: -14484.00
PHSC.L cash_flow (annual, 2023-03-31) — Change In Payable: -85655.00
PHSC.L cash_flow (annual, 2023-03-31) — Change In Receivables: 52006.00
PHSC.L cash_flow (annual, 2023-03-31) — Change In Working Capital: -48133.00
PHSC.L cash_flow (annual, 2023-03-31) — Changes In Cash: 100264.00
PHSC.L balance_sheet (annual, 2023-03-31) — Common Stock: 1184704.00
PHSC.L cash_flow (annual, 2023-03-31) — Common Stock Dividend Paid: -118470.00
PHSC.L balance_sheet (annual, 2023-03-31) — Common Stock Equity: 3638142.00
PHSC.L cash_flow (annual, 2023-03-31) — Common Stock Payments: 0.00
PHSC.L income_statement (annual, 2023-03-31) — Cost Of Revenue: 1612543.00
PHSC.L balance_sheet (annual, 2023-03-31) — Current Assets: 1624168.00
PHSC.L balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 25137.00
PHSC.L balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 25137.00
PHSC.L balance_sheet (annual, 2023-03-31) — Current Liabilities: 613478.00
PHSC.L cash_flow (annual, 2023-03-31) — Depreciation: 63034.00
PHSC.L cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 63034.00
PHSC.L income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 63034.00
PHSC.L income_statement (annual, 2023-03-31) — Depreciation Income Statement: 63034.00
PHSC.L income_statement (annual, 2023-03-31) — Diluted Average Shares: 11847019.00
PHSC.L income_statement (annual, 2023-03-31) — Diluted EPS: 2.05
PHSC.L income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 243259.00
PHSC.L income_statement (annual, 2023-03-31) — EBIT: 303252.00
PHSC.L income_statement (annual, 2023-03-31) — EBITDA: 366286.00